Delivery Order SPE2DB20D1109-SPE2DB25FP47T
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,036.15 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP vaccine syringes. The contract has a ceiling value of $1,363.72 and a period of performance through January 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $144,730 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562195770 INFANRIX DTAP SYRINGE 0.5ML. As the prime contractor, Amerisourcebergen will deliver the diphtheria, tetanus, and pertussis vaccine syringes to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on September 18, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $2,013 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561933838 INFANRIX DTAP syringes. As the prime contractor, Amerisourcebergen will deliver 0.5mL doses of the diphtheria, tetanus, and acellular pertussis vaccine to the agency from its location in Conshohocken, Pennsylvania. The order is to be completed by August 25, 2023 and was funded through the DLA's medical supplies procurement programs which support immunization and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5 mL) valued at $2,636.60 on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order, valued at $2,807.39, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 31, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,174.44 and a performance period ending on June 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...